Related Experiment Videos
Cervical cancer and microchimerism.
Donghyun Cha1, Kiarash Khosrotehrani, Youngtae Kim
1Division of Genetics, Departments of Obstetrics and Gynecology and Pediatrics, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA.
Obstetrics and Gynecology
|October 11, 2003
Summary
Microchimerism, the presence of fetal cells in maternal tissue, may play a role in cervical cancer development. Male fetal cells were detected in cervical cancer patients but not in controls, suggesting a link to disease progression.
Area of Science:
- Reproductive immunology
- Gynecologic oncology
- Cellular biology
Background:
- Microchimerism involves the transfer of cells between mother and fetus.
- The role of microchimerism in gynecologic malignancies remains largely unexplored.
Purpose of the Study:
- To investigate the presence and potential role of microchimerism in cervical cancer pathogenesis.
- To determine if fetal cells are detectable in cervical cancer tissue.
Main Methods:
- Analysis of cervical tissue from women with cervical cancer and controls using fluorescence in situ hybridization (FISH) for Y chromosomes.
- Immunolabeling to identify the phenotype of detected fetal cells (e.g., CD45, cytokeratin).
Main Results:
- Male fetal cells were detected in the cervical tissue of all tested cervical cancer patients.
- Fetal cells were absent in control subjects' tissue specimens.
- Detected fetal cells exhibited characteristics of immune cells (CD45+) and epithelial cells (cytokeratin+).
Conclusions:
- Cervical cancer may be associated with microchimerism, potentially due to fetomaternal cell trafficking.
- These findings suggest a broader role for microchimerism in women's diseases.